IVD Solutions

ELISA Immunoassay Solutions CLIA Immunoassay Solutions Molecular Diagnostic Solutions Point-of-Care Testing Solutions Cancer Research & Liquid Biopsy Solutions

HEPAVASE MA-96 (TMB) (Anti-HAV IgM)

High-specificity IgM Capture ELISA for acute HAV IgM antibodies. 98% sensitivity, 100% specificity. 10 µL sample, clinically validated, Taiwan DOH certified.

USEFUL RESOURCES

Add to List

> PRODUCT DESCRIPTION > SPECIFICATION > PERFORMANCE > ORDERING INFORMATION

PRODUCT DESCRIPTION

This product is designed as an IgM capture ELISA for detection of acute Hepatitis A virus (HAV) infection. The solid phase is coated with capture antibodies specific for HAV IgM, while the liquid phase includes purified peroxidase-conjugated antibodies. It is optimized to detect early infection through IgM antibodies.

SPECIFICATION

Number of wells	96
Principle	IgM Capture
Assay format	Qualitative
Total incubation time	150 minutes
Sample type	Serum / Plasma
Sample volume	10 μL
Reading wavelength	450nm
Storage	2-8°C
Certification	TFDA

PERFORMANCE

1570 hospitalized patients were tested. The results are as follows：

PERFORMANCE	Test Positive	Test Negative
Confirmed Positive	188	4
Confirmed Negative	0	1378

Inter-assay precision CV

< 20%

Intra-assay precision CV

< 15%

The diagnostic sensitivity is 98%；The diagnostic specificity is 100%

ORDERING INFORMATION

Catalogue No.	Product
4AME3	HEPAVASE MA-96 (TMB)